Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 5, 2025

Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View

Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.

Zacks Investment Research • Nov 6, 2025

Avanos Medical, Inc. (AVNS) Q3 2025 Earnings Call Transcript

Avanos Medical, Inc. ( AVNS ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Jason Pickett - Vice President of Tax & Treasurer David Pacitti - CEO & Director Scott Galovan - CFO & Senior VP Conference Call Participants Daniel Stauder - Citizens JMP Securities, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Avanos Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.

Seeking Alpha • Nov 5, 2025

Avanos Medical, Inc. Announces Third Quarter 2025 Results

Delivered double-digit growth in Specialty Nutrition Systems segment Closed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segment Raising and narrowing top-line guidance and adjusted EPS guidance for the full year ALPHARETTA, Ga. , Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2025 financial results.

PRNewsWire • Nov 5, 2025

Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates

Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.36 per share a year ago.

Zacks Investment Research • Nov 5, 2025

Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

ALPHARETTA, Ga. , Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed.

PRNewsWire • Oct 27, 2025

WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business

ANN ARBOR, Mich. , Oct. 23, 2025 /PRNewswire/ -- WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avanos Medical, Inc. (NYSE: AVNS) to acquire substantially all assets and rights related to Avanos' US Game Ready® orthopedic rental business.

PRNewsWire • Oct 23, 2025

Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up

Avanos Medical is deeply undervalued, with strong international expansion, aggressive M&A strategy, and a new CFO poised to drive inorganic growth. AVNS operates in high-growth markets, maintains a solid balance sheet with low debt, and trades at a significant discount to sector peers on earnings and book value. Ongoing transformation, divestitures, and stock repurchases are expected to enhance operating and free cash flow margins, further boosting investor appeal.

Seeking Alpha • Oct 5, 2025

Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio

AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.

Zacks Investment Research • Sep 18, 2025

Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care

ALPHARETTA, Ga. , Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas.

PRNewsWire • Sep 15, 2025